bioRxivCell Biology
BLOS1 mediates kinesin switch during endosomal recycling of LDL receptor
Abstract
Low-density lipoprotein receptor (LDLR) in hepatocytes plays a key role in normal clearance of circulating LDL and in whole body cholesterol homeostasis. The trafficking of LDLR is highly regulated in clathrin-dependent endocytosis, endosomal recycling and lysosomal degradation. Current studies have been focusing on its endocytosis and degradation. However, the detailed molecular and cellular mechanisms underlying its endosomal recycling are largely unknown. We found that BLOS1, a shared subunit of BLOC-1 and BORC, is involved in LDLR endosomal recycling. Loss of BLOS1 leads to less membrane LDLR and impairs LDL clearance from plasma in hepatocyte-specific BLOS1 knockout mice. BLOS1 interacts with kinesin-3, and that BLOS1 acts as a new adaptor for kinesin-2 to coordinate kinesin-3 and kinesin-2 during the long-range transport of recycling endosomes (REs) to plasma membrane along microtubule tracks to overcome hurdles at microtubule intersections. These findings provide new insights into REs anterograde transport and the pathogenesis of dyslipidemia.
- organism: mouse
- assay: proteomics
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Selective Targeting of Kinesin on Lipid Droplets in the Liver Reduces Serum Lipids
Subham Kumar Tripathy, Archisman Mahapatra, … Roop Mallik·bioRxiv·Nov 17, 2025
- Endothelial lipase facilitates low-density lipoprotein (LDL) uptake in LDL receptor deficiency by a heparan sulfate proteoglycan-dependent mechanism.
Olivia White, Zahra Aligabi, … Diego Lucero·bioRxiv·Mar 2, 2025
- Lipoprotein particles interact with membranes and transfer their cargo without receptors
B. Plochberger, T. Sych, … E. Sezgin·bioRxiv·Aug 27, 2020
- GOLIATH regulates LDLR availability and plasma LDL cholesterol levels
Bethan L. Clifford, Kelsey E. Jarrett, … Elizabeth J. Tarling·bioRxiv·Dec 9, 2020
- Targeting Liver Epsins Ameliorates Dyslipidemia in Atherosclerosis through Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9-Mediated Low-density Lipoprotein Receptor Degradation
Bo Zhu, Krishan Gupta, … Hong Chen·bioRxiv·Aug 26, 2024
- Live-cell imaging and lipidomics of low density lipoprotein containing intrinsically fluorescent cholesteryl esters
Alice Dupont Juhl, Richard R. Sprenger, … Daniel Wüstner·Analytical ChemistryPeer-reviewed·Feb 26, 2026